141 related articles for article (PubMed ID: 23265723)
1. [Risk assessment of thrombotic events after the use of activated factor VII].
Martínez López MC; Alcaraz Romero AJ; Martínez López AB; Fernández-Llamazares CM; Ramos Navarro C
An Pediatr (Barc); 2013 Sep; 79(3):177-81. PubMed ID: 23265723
[TBL] [Abstract][Full Text] [Related]
2. Recombinant Factor VIIa Is Associated With Increased Thrombotic Complications in Pediatric Cardiac Surgery Patients.
Downey L; Brown ML; Faraoni D; Zurakowski D; DiNardo JA
Anesth Analg; 2017 May; 124(5):1431-1436. PubMed ID: 28319507
[TBL] [Abstract][Full Text] [Related]
3. Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.
Pychyńska-Pokorska M; Pągowska-Klimek I; Krajewski W; Moll JJ
J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):987-94. PubMed ID: 21835642
[TBL] [Abstract][Full Text] [Related]
4. Thrombotic risk of recombinant factor seven in pediatric cardiac surgery: a single institution experience.
Karsies TJ; Nicol KK; Galantowicz ME; Stephens JA; Kerlin BA
Ann Thorac Surg; 2010 Feb; 89(2):570-6. PubMed ID: 20103344
[TBL] [Abstract][Full Text] [Related]
5. Recombinant factor seven therapy for postoperative bleeding in neonatal and pediatric cardiac surgery.
Agarwal HS; Bennett JE; Churchwell KB; Christian KG; Drinkwater DC; He Y; Taylor MB
Ann Thorac Surg; 2007 Jul; 84(1):161-8. PubMed ID: 17588404
[TBL] [Abstract][Full Text] [Related]
6. A Propensity-Score Matched Analysis on Outcomes Using Recombinant Activated Factor VII in Pediatric Cardiac Surgery.
Li Y; Zhao W; Luo Q; Wu X; Ding J; Yan F
J Cardiothorac Vasc Anesth; 2019 May; 33(5):1269-1275. PubMed ID: 30795967
[TBL] [Abstract][Full Text] [Related]
7. Recombinant activated factor VII in cardiac surgery: single-center experience.
Singh SP; Chauhan S; Choudhury M; Malik V; Choudhary SK
Asian Cardiovasc Thorac Ann; 2014 Feb; 22(2):148-54. PubMed ID: 24585784
[TBL] [Abstract][Full Text] [Related]
8. Off-label use of recombinant activated factor VII in intractable haemorrhage after cardiovascular surgery: an observational study of practices in 23 French cardiac centres (2005-7).
Hacquard M; Durand M; Lecompte T; Boini S; Briançon S; Carteaux JP
Eur J Cardiothorac Surg; 2011 Dec; 40(6):1320-7. PubMed ID: 21550261
[TBL] [Abstract][Full Text] [Related]
9. Review of the off-label use of recombinant activated factor VII in pediatric cardiac surgery patients.
Guzzetta NA; Russell IA; Williams GD
Anesth Analg; 2012 Aug; 115(2):364-78. PubMed ID: 22652310
[TBL] [Abstract][Full Text] [Related]
10. Recombinant factor VIIa (NovoSeven RT) use in high risk cardiac surgery.
Chapman AJ; Blount AL; Davis AT; Hooker RL
Eur J Cardiothorac Surg; 2011 Dec; 40(6):1314-8; discussion 1318-9. PubMed ID: 21601468
[TBL] [Abstract][Full Text] [Related]
11. rFVIIa in the treatment of persistent hemorrhage in pediatric patients on ECMO following surgery for congenital heart disease.
Veldman A; Neuhaeuser C; Akintuerk H; Thul J; Gehron J; Schranz D; Michel-Behnke I
Paediatr Anaesth; 2007 Dec; 17(12):1176-81. PubMed ID: 17986036
[TBL] [Abstract][Full Text] [Related]
12. Is recombinant activated factor VII effective in the treatment of excessive bleeding after paediatric cardiac surgery?
Okonta KE; Edwin F; Falase B
Interact Cardiovasc Thorac Surg; 2012 Oct; 15(4):690-4. PubMed ID: 22811512
[TBL] [Abstract][Full Text] [Related]
13. Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease.
Razon Y; Erez E; Vidne B; Birk E; Katz J; Tamari H; Dagan O
Paediatr Anaesth; 2005 Mar; 15(3):235-40. PubMed ID: 15725322
[TBL] [Abstract][Full Text] [Related]
14. Recombinant activated factor VII in cardiac surgery: experience from the Australian and New Zealand Haemostasis Registry.
Dunkley S; Phillips L; McCall P; Brereton J; Lindeman R; Jankelowitz G; Cameron P
Ann Thorac Surg; 2008 Mar; 85(3):836-44. PubMed ID: 18291152
[TBL] [Abstract][Full Text] [Related]
15. Factor VII for excessive bleeding following congenital heart disease surgery.
Changlani DK; Devendaran V; Murmu UC; Ganesan S; Varghese R; Kumar RS
Asian Cardiovasc Thorac Ann; 2012 Apr; 20(2):120-5. PubMed ID: 22499956
[TBL] [Abstract][Full Text] [Related]
16. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder.
Yilmaz D; Karapinar B; Balkan C; Akisü M; Kavakli K
Pediatr Hematol Oncol; 2008 Jun; 25(4):301-11. PubMed ID: 18484474
[TBL] [Abstract][Full Text] [Related]
17. Recombinant activated factor VII for hemorrhage after pediatric cardiac surgery.
Singh SP; Chauhan S; Choudhary M; Vasdev S; Talwar S
Asian Cardiovasc Thorac Ann; 2012 Feb; 20(1):19-23. PubMed ID: 22371937
[TBL] [Abstract][Full Text] [Related]
18. Off-label recombinant factor VIIa use and thrombosis in children: a multi-center cohort study.
Witmer CM; Huang YS; Lynch K; Raffini LJ; Shah SS
J Pediatr; 2011 May; 158(5):820-825.e1. PubMed ID: 21146180
[TBL] [Abstract][Full Text] [Related]
19. Intraoperative use of recombinant activated factor VII during complex aortic surgery.
Goksedef D; Panagopoulos G; Nassiri N; Levine RL; Hountis PG; Plestis KA
J Thorac Cardiovasc Surg; 2012 May; 143(5):1198-204. PubMed ID: 22285329
[TBL] [Abstract][Full Text] [Related]
20. Recombinant factor VIIa for intractable blood loss after cardiac surgery: a propensity score-matched case-control analysis.
Karkouti K; Beattie WS; Wijeysundera DN; Yau TM; McCluskey SA; Ghannam M; Sutton D; van Rensburg A; Karski J
Transfusion; 2005 Jan; 45(1):26-34. PubMed ID: 15647015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
